Article

MULTISCALE ANALYSIS AND VALIDATION OF EFFECTIVE DRUG COMBINATIONS TARGETING DRIVER KRAS MUTATIONS IN NON-SMALL CELL LUNG CANCER

2022-09-22

Abstract excerpt

1. Pharmacogenomics is a rapidly growing field with the goal of providing personalized care to every patient. Previously, we developed the Computational Analysis of Novel Drug Opportunities (CANDO) platform for multiscale therapeutic discovery to screen optimal compounds for any indication/disease by performing analytics on their interactions with large protein libraries. We implemented a comprehensive precision m...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e47ff2b7-5c6f-5ee1-b956-aea367da677c
DOI: 10.1101/2022.09.21.508953

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

MULTISCALE ANALYSIS AND VALIDATION OF EFFECTIVE DRUG COMBINATIONS TARGETING DRIVER KRAS MUTATIONS IN NON-SMALL CELL LUNG CANCERDOI 10.1101/2022.09.21.508953Read

Multiscale Analysis and Validation of Effective Drug Combinations Targeting Driver KRAS Mutations in Non-Small Cell Lung Cancer.Semantic proximity Read

Integrative omics analyses broaden treatment targets in human cancer.Semantic proximity Read

An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer.Semantic proximity Read

SIGNATURE-DRIVEN REPURPOSING OF MIDOSTAURIN FOR COMBINATION WITH MEK1/2 AND KRASG12C INHIBITORS IN LUNG CANCERSemantic proximity Read

Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergismsSemantic proximity Read

Anticancer Target Combinations: Network-Informed Signaling-Based Approach to DiscoverySemantic proximity Read

Combining cutting edge computational and experimental methods for targeting KRAS mutations in non-small cell lung cancer.Semantic proximity Read

CombPDX: a unified statistical framework for evaluating drug synergism in patient-derived xenograftsSemantic proximity Read

Genomic classification of the RAS network identifies a personalized treatment strategy for lung cancer.Semantic proximity Read

Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.Semantic proximity Read

Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset.Semantic proximity Read

SYNERGxDB: an integrative pharmacogenomic portal to identify synergistic drug combinations for precision oncology.Semantic proximity Read